Thimerosal (thiomersal) is considered the classic lipophilic sulfhydryl reactive agent having been used by scientists for over 30 years to inhibit numerous enzymes and cellular processes (see Thimerosal Studies) virtually all of which are vital for normal cellular functioning (see Thimerosal/sld041.htm).  Moreover, the levels of thimerosal required to produce these many toxic effects were often found to be much lower than the concentrations of thimerosal included in vaccines.  Given these facts, the vaccine manufacturers, the FDA and the CDC must surely have conducted numerous studies on the safety of thimerosal containing vaccines before ever allowing, much less recommending, they be administered to newborns and infants.  If so, where are the results of those studies published?